Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)
Accession | 1oxq |
Experiment type | X-ray |
Resolution | 2.3 Å |
Chains | A, B, C, D, E, F |
Released | 26 August 2003 |
Chain A ( Q96CA5)
Chain B ( Q96CA5)
Chain C ( Q96CA5)
Chain D ( Q96CA5)
Chain E ( Q96CA5)
References
1. Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP) Franklin, M.C., Kadkhodayan, S., Ackerly, H., Alexandru, D., Distefano, M.D., Elliott, L.O., Flygare, J.A., Mausisa, G., Okawa, D.C., Ong, D., Vucic, D., Deshayes, K., Fairbrother, W.J. Biochemistry 42, 8223-8231, (2003). View articlePMID: 12846571
2. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas Vucic, D., Stennicke, H.R., Pisabarro, M.T., Salvesen, G.S., Dixit, V.M. Curr. Biol. 10, 1359-1366, (2000). View article
3. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) Vucic, D., Deshayes, K., Ackerly, H., Pisabarro, M.T., Kadkhodayan, S., Fairbrother, W.J., Dixit, V.M. J. Biol. Chem. 277, 12275-12279, (2002). View article